DK1341779T3 - Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion - Google Patents

Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion

Info

Publication number: DK1341779T3
Authority: DK; Denmark
Prior art keywords: beta; amyloid production; heterocyclic sulfonamide; sulfonamide inhibitors; inhibitors
Prior art date: 2000-12-13

Application number

DK01993277T

Other languages

English (en)

Inventor

Anthony Frank Kreft

Derek Cecil Cole

Kevin Roger Woller

Joseph Raymond Stock

Dennis Michael Kurbrak

Kristina Martha Kutterer

David Scott Casebier

William Jay Moore

George Diamanitis

Original Assignee

Wyeth Corp

Arqule Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-13

Filing date

2001-12-11

Publication date

2006-10-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22966854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1341779(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-12-11 Application filed by Wyeth Corp, Arqule Inc filed Critical Wyeth Corp

2006-10-30 Application granted granted Critical

2006-10-30 Publication of DK1341779T3 publication Critical patent/DK1341779T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK01993277T 2000-12-13 2001-12-11 Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion DK1341779T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US25510500P	2000-12-13	2000-12-13

Publications (1)

Publication Number	Publication Date
DK1341779T3 true DK1341779T3 (da)	2006-10-30

Family

ID=22966854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01993277T DK1341779T3 (da)	2000-12-13	2001-12-11	Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion

Country Status (27)

Country	Link
US (5)	US6610734B2 (da)
EP (1)	EP1341779B1 (da)
JP (2)	JP2004517892A (da)
KR (1)	KR100869061B1 (da)
CN (2)	CN1800176A (da)
AR (1)	AR035516A1 (da)
AT (1)	ATE330950T1 (da)
AU (1)	AU2002245123B2 (da)
BR (1)	BR0116063A (da)
CA (1)	CA2436526C (da)
CY (1)	CY1105441T1 (da)
DE (1)	DE60121032T2 (da)
DK (1)	DK1341779T3 (da)
EA (1)	EA009035B1 (da)
ES (1)	ES2267853T3 (da)
HU (1)	HUP0303857A3 (da)
IL (3)	IL156268A0 (da)
MX (1)	MXPA03005255A (da)
NO (1)	NO328885B1 (da)
NZ (2)	NZ538100A (da)
PL (1)	PL365950A1 (da)
PT (1)	PT1341779E (da)
SG (1)	SG128491A1 (da)
SI (1)	SI1341779T1 (da)
TW (1)	TWI235155B (da)
WO (1)	WO2002057252A2 (da)
ZA (1)	ZA200304135B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003528076A (ja) *	2000-03-20	2003-09-24	メルクシャープエンドドームリミテッド	スルホンアミド置換架橋ビシクロアルキル誘導体
US6657070B2 (en)	2000-12-13	2003-12-02	Wyeth	Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
HUP0303857A3 (en) *	2000-12-13	2007-07-30	Wyeth Corp	Heterocyclic sulifonamide inhibitors of beta amyloid production
AU2002359519B2 (en)	2001-12-11	2009-07-16	Wyeth	Process for the synthesis of chirally pure beta-amino-alcohols
SG143986A1 (en) *	2002-06-11	2008-07-29	Wyeth Corp	Substituted phenylsulfonamide inhibitors of beta amyloid production
WO2004043916A1 (en)	2002-11-12	2004-05-27	Merck & Co., Inc.	Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
TWI336698B (en) *	2003-03-31	2011-02-01	Wyeth Corp	Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
WO2005000798A1 (ja) *	2003-06-30	2005-01-06	Daiichi Pharmaceutical Co., Ltd.	複素環メチルスルホン誘導体
DE602005016775D1 (de) *	2004-01-16	2009-11-05	Wyeth Corp	Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
WO2006078753A1 (en)	2005-01-18	2006-07-27	Elan Pharmaceuticals, Inc.	N-substituted heterocyclic sulfonamides
US7893267B2 (en) *	2005-03-14	2011-02-22	High Point Pharmaceuticals, Llc	Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
TW200800959A (en) *	2005-06-10	2008-01-01	Wyeth Corp	Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
GB0602951D0 (en) *	2006-02-14	2006-03-29	Novartis Ag	Organic Compounds
BRPI0707742A2 (pt) *	2006-02-17	2011-05-10	Wyeth Corp	processo para preparar um composto
RU2008129797A (ru) *	2006-02-17	2010-03-27	Вайет (Us)	Способы получения сульфонамид-замещенных спиртов и их промежуточных соединений
US7476762B2 (en) *	2006-04-21	2009-01-13	Wyeth	Methods for preparing sulfonamide compounds
US7550629B2 (en) *	2006-04-21	2009-06-23	Wyeth	Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors
EP2010478A1 (en) *	2006-04-21	2009-01-07	Wyeth	Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof
TW200811144A (en) *	2006-06-09	2008-03-01	Wyeth Corp	Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
TW200808740A (en) *	2006-06-09	2008-02-16	Wyeth Corp	Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
TW200808741A (en) *	2006-06-09	2008-02-16	Wyeth Corp	6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
WO2008059238A1 (en) *	2006-11-17	2008-05-22	Astrazeneca Ab	Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer
WO2008064320A2 (en) *	2006-11-21	2008-05-29	University Of Virginia Patent Foundation	Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
US20080262228A1 (en) *	2006-11-28	2008-10-23	Wyeth	Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof
TW200901974A (en) *	2007-01-16	2009-01-16	Wyeth Corp	Compounds, compositions, and methods of making and using them
CA2676715A1 (en)	2007-02-12	2008-08-21	Merck & Co., Inc.	Piperazine derivatives for treatment of ad and related conditions
CL2008002060A1 (es) *	2007-07-16	2008-11-21	Wyeth Corp	Compuestos derivados de sulfonamida, inhibidores de la produccion de beta amiloide; metodo de preparacion; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento de enfermedades tales como alzheimer, angiopatia amiloide, sindrome de down, entre otras.
TW200911778A (en) *	2007-07-16	2009-03-16	Wyeth Corp	Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
PE20090810A1 (es) *	2007-07-16	2009-07-20	Wyeth Corp	Procesos e intermediarios para la preparacion de compuestos de sulfonamida heterociclica
ES2413504T3 (es)	2007-12-21	2013-07-16	Ligand Pharmaceuticals Inc.	Moduladores selectivos del receptor de andrógeno (SARM) y usos de los mismos
CL2009000019A1 (es) *	2008-01-11	2009-05-22	Wyeth Corp	Compuestos derivados de aril sulfonamida que contienen o-sulfato u o-fosfato; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso como profarmacos para incrementar la semivida de circulacion de compuestos inhibidores de la produccion de beta-amiloide, utiles en el tratamiento del alzheimer y cancer.
EP2291181B9 (en)	2008-04-18	2013-09-11	University College Dublin National University Of Ireland, Dublin	Captodiamine for the treatment of depression symptoms
CA2941035A1 (en)	2008-07-28	2010-02-04	Blanchette Rockefeller Neurosciences Institute	Pkc-activating compounds for the treatment of neurodegenerative diseases
JP2013514287A (ja)	2009-12-17	2013-04-25	メルクパテントゲゼルシャフトミットベシュレンクテルハフツング	スフィンゴシンキナーゼの阻害薬
US9802954B2 (en)	2011-08-24	2017-10-31	Boehringer Ingelheim International Gmbh	Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US10245249B2 (en)	2013-01-18	2019-04-02	Cardioxyl Pharmaceuticals, Inc.	Pharmaceutical compositions comprising nitroxyl donors
CN104370769B (zh) *	2013-08-14	2017-05-31	重庆博腾制药科技股份有限公司	一种制备羟基金刚烷甘氨酸衍生物的方法
EP3613418A1 (en)	2014-01-17	2020-02-26	Ligand Pharmaceuticals, Inc.	Methods and compositions for modulating hormone levels
WO2017155890A1 (en) *	2016-03-11	2017-09-14	Ohio State Innovation Foundation	Novel small molecule antimicrobials
BR112021020864A2 (pt)	2019-04-19	2021-12-14	Ligand Pharm Inc	Formas cristalinas e métodos de produção de formas cristalinas de um composto
DE202022106287U1 (de)	2022-11-09	2022-11-21	Ahmad Salawi	Eine Methode zur Synthese und biologischen Bewertung von neuen Sulfonamid-Analoga

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US656536A (en) *	1899-12-28	1900-08-21	David Fitzgibbons	Boiler.
US3376523A (en) *	1966-12-27	1968-04-02	Univ California	Transient-suppressing magnetic transmission line
US5464853A (en)	1993-05-20	1995-11-07	Immunopharmaceutics, Inc.	N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en)	1993-05-20	1996-11-05	Texas Biotechnology Corporation	Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en)	1993-05-20	1996-05-07	Immunopharmaceutics, Inc.	N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en)	1993-05-20	1997-01-07	Texas Biotechnology Corporation	Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en)	1993-05-20	1997-01-14	Texas Biotechnology Corporation	Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
KR920019763A (ko)	1991-04-26	1992-11-19	모리다 가즈라	아졸 화합물, 그의 제조방법 및 용도
GB9110722D0 (en)	1991-05-17	1991-07-10	Fujisawa Pharmaceutical Co	Amine derivatives
US5766846A (en)	1992-07-10	1998-06-16	Athena Neurosciences	Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5968942A (en)	1992-08-25	1999-10-19	G. D. Searle & Co.	α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
JP3599287B2 (ja) *	1993-04-28	2004-12-08	三菱化学株式会社	スルホンアミド誘導体
US6342610B2 (en) *	1993-05-20	2002-01-29	Texas Biotechnology Corp.	N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en)	1994-05-20	2002-04-23	Texas Biotechnology Corporation	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
NZ264143A (en)	1993-08-09	1996-11-26	Lilly Co Eli	Use of an aspartyl protease inhibitor to inhibit beta-amyloid peptide production
US5519040A (en)	1994-04-29	1996-05-21	Allergan	Substituted thiazole sulfonamides as antiglaucoma agents
US5561146A (en) *	1994-06-10	1996-10-01	Bristol-Myers Squibb Company	Modified guanidino and amidino thrombin inhibitors
US5624937A (en)	1995-03-02	1997-04-29	Eli Lilly And Company	Chemical compounds as inhibitors of amyloid beta protein production
JPH09136878A (ja) *	1995-09-12	1997-05-27	Ono Pharmaceut Co Ltd	テトラゾール誘導体
EP0761680A3 (en) *	1995-09-12	1999-05-06	Ono Pharmaceutical Co., Ltd.	Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
ES2293651T3 (es) *	1995-11-28	2008-03-16	Cephalon, Inc.	Inhibidores de cisteina y serina proteasas derivados de aminoacidos d.
WO1997024340A1 (en)	1995-12-27	1997-07-10	Takeda Chemical Industries, Ltd.	Oxazole derivatives, their production and use
JPH09235276A (ja) *	1995-12-27	1997-09-09	Takeda Chem Ind Ltd	オキサゾール誘導体、その製造法および用途
US5877193A (en) *	1996-07-19	1999-03-02	Hoffmann-La Roche Inc.	Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
PL331338A1 (en)	1996-07-22	1999-07-05	Monsanto Co	Thiosulphonamidic metaloprotease inhibitors
US5703129A (en)	1996-09-30	1997-12-30	Bristol-Myers Squibb Company	5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
WO1998016504A2 (en) *	1996-10-11	1998-04-23	Warner-Lambert Company	SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
US5985930A (en)	1996-11-21	1999-11-16	Pasinetti; Giulio M.	Treatment of neurodegenerative conditions with nimesulide
TR199901132T2 (xx)	1996-11-22	1999-08-23	Elan Pharmaceuticals, Inc.	N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler.
DE19650196A1 (de) *	1996-12-04	1998-06-10	Bayer Ag	Thienylsulfonylamino(thio)carbonylverbindungen
GB9725138D0 (en) *	1997-11-27	1998-01-28	Pharmacia & Upjohn Spa	Thiophenesulfonamide compounds
JPH11343279A (ja)	1998-03-16	1999-12-14	Shionogi & Co Ltd	スルホンアミド誘導体およびそれらを含有するＴＮＦ―α産生抑制剤
US5981168A (en)	1998-05-15	1999-11-09	The University Of British Columbia	Method and composition for modulating amyloidosis
KR20010052503A (ko) *	1998-06-03	2001-06-25	다니엘 피. 맥컬럼	Ｎ-헤테로사이클릭 카복실산 또는 카복실산 등입체의ｎ-결합된 설폰아미드
US7410995B1 (en)	1998-08-14	2008-08-12	Gpi Nil Holdings Inc.	N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
IL144781A0 (en)	1999-02-26	2002-06-30	Merck & Co Inc	Novel sulfonamide compounds and uses thereof
PL351374A1 (en)	1999-04-19	2003-04-07	Shionogi & Co	Sulfonamide derivatives having oxadiazole rings
EP1088815A1 (en) *	1999-09-28	2001-04-04	Applied Research Systems ARS Holding N.V.	Pharmaceutically active sulfonyl amino acid derivatives
EP1088821A1 (en) *	1999-09-28	2001-04-04	Applied Research Systems ARS Holding N.V.	Pharmaceutically active sulfonamide derivatives
EP1222176A1 (en) *	1999-10-08	2002-07-17	Bristol-Myers Squibb Pharma Company	AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
HUP0303857A3 (en)	2000-12-13	2007-07-30	Wyeth Corp	Heterocyclic sulifonamide inhibitors of beta amyloid production
US6657070B2 (en)	2000-12-13	2003-12-02	Wyeth	Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
EP1461332A4 (en)	2001-12-11	2009-10-21	Wyeth Corp	PRODUCTION OF ALPHA-AMINO ACIDS AND CHIRALLY PURE ALPHA-AMINO N-SULFONYL ACIDS
AU2002359519B2 (en)	2001-12-11	2009-07-16	Wyeth	Process for the synthesis of chirally pure beta-amino-alcohols
SG143986A1 (en) *	2002-06-11	2008-07-29	Wyeth Corp	Substituted phenylsulfonamide inhibitors of beta amyloid production
TWI336698B (en) *	2003-03-31	2011-02-01	Wyeth Corp	Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof

2001
- 2001-12-11 HU HU0303857A patent/HUP0303857A3/hu unknown
- 2001-12-11 AU AU2002245123A patent/AU2002245123B2/en not_active Ceased
- 2001-12-11 SI SI200130604T patent/SI1341779T1/sl unknown
- 2001-12-11 SG SG200503628A patent/SG128491A1/en unknown
- 2001-12-11 PT PT01993277T patent/PT1341779E/pt unknown
- 2001-12-11 MX MXPA03005255A patent/MXPA03005255A/es active IP Right Grant
- 2001-12-11 US US10/014,304 patent/US6610734B2/en not_active Expired - Fee Related
- 2001-12-11 BR BR0116063-0A patent/BR0116063A/pt not_active Application Discontinuation
- 2001-12-11 JP JP2002557933A patent/JP2004517892A/ja not_active Withdrawn
- 2001-12-11 AT AT01993277T patent/ATE330950T1/de active
- 2001-12-11 NZ NZ538100A patent/NZ538100A/en unknown
- 2001-12-11 KR KR1020037007928A patent/KR100869061B1/ko not_active Expired - Fee Related
- 2001-12-11 IL IL15626801A patent/IL156268A0/xx active IP Right Review Request
- 2001-12-11 DK DK01993277T patent/DK1341779T3/da active
- 2001-12-11 EP EP01993277A patent/EP1341779B1/en not_active Expired - Lifetime
- 2001-12-11 CN CNA2005100035919A patent/CN1800176A/zh active Pending
- 2001-12-11 WO PCT/US2001/048375 patent/WO2002057252A2/en not_active Ceased
- 2001-12-11 DE DE60121032T patent/DE60121032T2/de not_active Expired - Lifetime
- 2001-12-11 CN CNB018205186A patent/CN1263750C/zh not_active Expired - Fee Related
- 2001-12-11 PL PL01365950A patent/PL365950A1/xx not_active IP Right Cessation
- 2001-12-11 EA EA200300674A patent/EA009035B1/ru not_active IP Right Cessation
- 2001-12-11 CA CA2436526A patent/CA2436526C/en not_active Expired - Fee Related
- 2001-12-11 ES ES01993277T patent/ES2267853T3/es not_active Expired - Lifetime
- 2001-12-11 NZ NZ526213A patent/NZ526213A/en unknown
- 2001-12-12 AR ARP010105782A patent/AR035516A1/es not_active Application Discontinuation
- 2001-12-12 TW TW090130721A patent/TWI235155B/zh active
2003
- 2003-05-28 ZA ZA200304135A patent/ZA200304135B/en unknown
- 2003-06-02 IL IL156268A patent/IL156268A/en not_active IP Right Cessation
- 2003-06-05 US US10/455,674 patent/US6878742B2/en not_active Expired - Fee Related
- 2003-06-11 NO NO20032645A patent/NO328885B1/no not_active IP Right Cessation
2005
- 2005-03-16 US US11/081,784 patent/US7691884B2/en not_active Expired - Fee Related
2006
- 2006-09-14 CY CY20061101305T patent/CY1105441T1/el unknown
2008
- 2008-01-17 IL IL188853A patent/IL188853A0/en unknown
2009
- 2009-10-09 US US12/576,513 patent/US7842718B2/en not_active Expired - Fee Related
2010
- 2010-06-24 JP JP2010144307A patent/JP2010265280A/ja not_active Withdrawn
- 2010-10-19 US US12/907,123 patent/US20110034513A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2436526C (en)	2010-10-19
ZA200304135B (en)	2004-09-03
AU2002245123B2 (en)	2007-05-24
KR20040018318A (ko)	2004-03-03
KR100869061B1 (ko)	2008-11-17
CY1105441T1 (el)	2010-07-28
WO2002057252A3 (en)	2002-12-12
IL156268A0 (en)	2004-01-04
JP2004517892A (ja)	2004-06-17
SG128491A1 (en)	2007-01-30
EP1341779A2 (en)	2003-09-10
MXPA03005255A (es)	2004-10-14
DE60121032T2 (de)	2007-01-11
DE60121032D1 (de)	2006-08-03
HUP0303857A2 (hu)	2004-03-29
SI1341779T1 (sl)	2006-12-31
HUP0303857A3 (en)	2007-07-30
AR035516A1 (es)	2004-06-02
CN1800176A (zh)	2006-07-12
NO20032645L (no)	2003-08-05
CN1503790A (zh)	2004-06-09
JP2010265280A (ja)	2010-11-25
NZ538100A (en)	2006-07-28
TWI235155B (en)	2005-07-01
CA2436526A1 (en)	2002-07-25
US20100022594A1 (en)	2010-01-28
NO20032645D0 (no)	2003-06-11
US20030229127A1 (en)	2003-12-11
IL188853A0 (en)	2011-08-01
US20020183361A1 (en)	2002-12-05
US7842718B2 (en)	2010-11-30
US6610734B2 (en)	2003-08-26
ATE330950T1 (de)	2006-07-15
BR0116063A (pt)	2004-08-03
WO2002057252A2 (en)	2002-07-25
EA009035B1 (ru)	2007-10-26
CN1263750C (zh)	2006-07-12
NZ526213A (en)	2005-05-27
HK1059619A1 (en)	2004-07-09
NO328885B1 (no)	2010-06-07
ES2267853T3 (es)	2007-03-16
PT1341779E (pt)	2006-10-31
EA200300674A1 (ru)	2004-06-24
IL156268A (en)	2008-04-13
PL365950A1 (en)	2005-01-24
US20110034513A1 (en)	2011-02-10
US6878742B2 (en)	2005-04-12
EP1341779B1 (en)	2006-06-21
US20050196813A1 (en)	2005-09-08
US7691884B2 (en)	2010-04-06

Publication	Publication Date	Title
DK1341779T3 (da)	2006-10-30	Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion
DK1438306T3 (da)	2014-06-23	Derivater af UK-2A
DK1360169T3 (da)	2007-11-26	Succinatsalt af O-desmethyl-venlafaxin
DK1315694T3 (da)	2005-08-08	Inhibitorer af alpha-4-medieret celleadhæsion
AR028567A1 (es)	2003-05-14	Nuevos derivados de fenil-propargileter
AR028596A1 (es)	2003-05-14	Nuevos derivados de fenilglicina
DK1077943T3 (da)	2009-03-16	Heterocykliske inhibitorer af p38
DK1252144T3 (da)	2010-04-19	Substituerede glutarimider og deres anvendelse som inhibitorer af IL-12-produktionen
DE60236226D1 (de)	2010-06-10	Verbesserung der Altersweitsichtigkeit
DE60221977D1 (de)	2007-10-04	Pro-pharmakon von cox-2-inhibitoren
DK1307263T3 (da)	2005-08-22	Hidtil ukendt anvendelse af lipaseinhibitorer
DK1686113T3 (da)	2012-02-20	Inhibitorer af aspartylprotease
DK1458447T3 (da)	2010-01-18	Kombination af cytokrom-p450-beroende proteasinhibitorer
CY2009001I1 (el)	2009-11-04	Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
EE04930B1 (et)	2007-12-17	K?rgkontsentreeritud stabiilsed meloksikaami lahused
NO20050118D0 (no)	2005-01-10	Substituerte fenylsulfonamidinhibitorer av beta-amyolid produksjon
ATE282038T1 (de)	2004-11-15	Kristallin form ii von cabergolin
NO20023956D0 (no)	2002-08-20	Priperidin- og piperazinsubstituerte N-hydroksyformamider som inhibitorer av metalloproteinaser
NO20025659L (no)	2002-11-25	Heterocykliske forbindelser
PT1322592E (pt)	2004-12-31	Derivados substituidos de 1-aminobutan-3-ol
IS6620A (is)	2002-11-14	Nýr fjölgervingur V af tórasemíði
EE200200389A (et)	2003-10-15	Imidasooli uued derivaadid
DE60007360T2 (de)	2004-10-07	Amorphe modifikation von torasemid
EE200100381A (et)	2002-12-16	Morfolinobensamiidi uued soolad
DK1440067T3 (da)	2005-04-11	N-formyl-derivater af paroxetin